After a 6-day court trial, the Federal Trade Commission successfully blocked Edwards Lifesciences from buying JenaValve over ...

BioAge’s NLRP3 inhibitor has shown potential to reduce high-sensitivity C-reactive protein (hsCRP), a key marker of ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Helps individuals living with heart failure, or those at risk of developing it, by reducing complications and lowering the risk of serious cardiovascular problems ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

Rapid weight loss can increase gallstone formation, and hospitalists have reported more cases of biliary colic and ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection This paper provides practical advice on risk stratification, antithrombotic prophylaxis, and ...

Physicians used significantly lower amounts of two heart drugs in hospital settings following major price spikes on the medications, according to Cleveland Clinic research published Thursday in The ...

The list of health benefits from weight loss drugs is long, but they last only as long as people take them.

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study from Karolinska Institutet published in Alzheimer's & Dementia: The Journal of the Alzheimer's ...